Parsons Capital Management Inc Amgen Inc Transaction History

Parsons Capital Management Inc

  • $1.55 Billion
  • Q3 2024

A detailed history of Parsons Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Parsons Capital Management Inc holds 21,650 shares of AMGN stock, worth $6.38 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
21,650
Previous 21,935 1.3%
Holding current value
$6.38 Million
Previous $6.85 Million 1.78%
% of portfolio
0.45%
Previous 0.47%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$309.38 - $337.38 $88,173 - $96,153
-285 Reduced 1.3%
21,650 $6.98 Million
Q2 2024

Jul 19, 2024
SELL
$262.75 - $319.31 $17,604 - $21,393
-67 Reduced 0.3%
21,935 $6.85 Million
Q1 2024

Apr 22, 2024
SELL
$268.87 - $324.56 $50,816 - $61,341
-189 Reduced 0.85%
22,002 $6.26 Million
Q4 2023

Jan 22, 2024
SELL
$255.7 - $288.46 $511 - $576
-2 Reduced 0.01%
22,191 $6.39 Million
Q3 2023

Nov 06, 2023
SELL
$218.65 - $271.46 $37,389 - $46,419
-171 Reduced 0.76%
22,193 $5.96 Million
Q2 2023

Aug 04, 2023
SELL
$214.27 - $253.37 $4,928 - $5,827
-23 Reduced 0.1%
22,364 $4.97 Million
Q1 2023

Apr 17, 2023
SELL
$225.79 - $275.2 $71,801 - $87,513
-318 Reduced 1.4%
22,387 $5.41 Million
Q4 2022

Feb 13, 2023
BUY
$229.03 - $291.01 $294,990 - $374,820
1,288 Added 6.01%
22,705 $5.96 Million
Q3 2022

Oct 26, 2022
BUY
$224.46 - $253.15 $12,794 - $14,429
57 Added 0.27%
21,417 $4.83 Million
Q2 2022

Jul 29, 2022
BUY
$230.71 - $256.74 $18,226 - $20,282
79 Added 0.37%
21,360 $5.2 Million
Q1 2022

May 02, 2022
SELL
$219.27 - $242.57 $30,039 - $33,232
-137 Reduced 0.64%
21,281 $5.15 Million
Q4 2021

Feb 07, 2022
SELL
$198.88 - $227.6 $198,880 - $227,600
-1,000 Reduced 4.46%
21,418 $4.82 Million
Q3 2021

Nov 09, 2021
SELL
$212.27 - $248.7 $15,707 - $18,403
-74 Reduced 0.33%
22,418 $4.77 Million
Q2 2021

Aug 03, 2021
SELL
$233.58 - $259.14 $15,182 - $16,844
-65 Reduced 0.29%
22,492 $5.48 Million
Q1 2021

Apr 28, 2021
BUY
$221.91 - $258.6 $2,219 - $2,586
10 Added 0.04%
22,557 $5.61 Million
Q4 2020

Feb 08, 2021
SELL
$216.38 - $257.67 $23,585 - $28,086
-109 Reduced 0.48%
22,547 $5.18 Million
Q3 2020

Oct 29, 2020
BUY
$234.65 - $260.95 $67,813 - $75,414
289 Added 1.29%
22,656 $5.76 Million
Q2 2020

Aug 10, 2020
BUY
$197.81 - $242.74 $102,663 - $125,982
519 Added 2.38%
22,367 $5.28 Million
Q1 2020

May 05, 2020
BUY
$182.24 - $241.7 $36,812 - $48,823
202 Added 0.93%
21,848 $4.43 Million
Q4 2019

Feb 03, 2020
BUY
$189.21 - $243.2 $18,542 - $23,833
98 Added 0.45%
21,646 $5.22 Million
Q3 2019

Nov 12, 2019
SELL
$174.11 - $208.62 $131,453 - $157,508
-755 Reduced 3.39%
21,548 $4.17 Million
Q2 2019

Aug 01, 2019
SELL
$166.7 - $195.41 $22,504 - $26,380
-135 Reduced 0.6%
22,303 $4.11 Million
Q1 2019

Apr 26, 2019
SELL
$180.87 - $203.88 $73,071 - $82,367
-404 Reduced 1.77%
22,438 $4.26 Million
Q4 2018

Feb 01, 2019
BUY
$178.4 - $208.25 $27,295 - $31,862
153 Added 0.67%
22,842 $4.45 Million
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $11,858 - $13,368
64 Added 0.28%
22,689 $4.7 Million
Q2 2018

Aug 09, 2018
BUY
$166.05 - $186.51 $54,962 - $61,734
331 Added 1.48%
22,625 $0
Q1 2018

May 07, 2018
SELL
$169.43 - $198.0 $102,166 - $119,394
-603 Reduced 2.63%
22,294 $3.8 Million
Q4 2017

Feb 02, 2018
BUY
$168.79 - $188.59 $43,041 - $48,090
255 Added 1.13%
22,897 $3.98 Million
Q3 2017

Oct 26, 2017
BUY
$167.29 - $191.0 $3.79 Million - $4.32 Million
22,642
22,642 $4.22 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email